Design and synthesis of boron containing potential pan-RAR inverse agonists

Tetrahedron Letters

Volumn 53, Issue 11, 2012, Pages 1316-1318

  Das, Bhaskar C ^a   Tang, Xiang Ying ^b   Evans, Todd ^a  

^a WEILL CORNELL MEDICAL COLLEGE   (United States)

^b ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

Author keywords

Boron containing retinoids; Oxadiazole; Peptidomimetics; RAR inverse agonist; Wittig reaction

Indexed keywords

1 TETRALONE DERIVATIVE; 5,5 DIMETHYL 8 (PHENYLETHYNYL) 5,6 DIHYDRONAPHTHALENE 2 CARBALDEHYDE; 7 BROMO 4,4 DIMETHYL 3,4 DIHYDRONAPHTHALEN 1(2H)ONE; ALDEHYDE DERIVATIVE; BORON; CARBOXYLIC ACID; OXADIAZOLE DERIVATIVE; RETINOIC ACID RECEPTOR AGONIST; RETINOID DERIVATIVE; UNCLASSIFIED DRUG;

AGONIST; ALKYLATION; ARTICLE; DERIVATIZATION; DRUG DESIGN; DRUG STRUCTURE; DRUG SYNTHESIS; DRUG TRANSFORMATION; WITTIG REACTION;

EID: 84856730990     PISSN: 00404039     EISSN: 18733581     Source Type: Journal    
DOI: 10.1016/j.tetlet.2011.12.118     Document Type: Article

References (32)

1. P. Germain, P. Gaudon, V. Pogenberg, S. Sanglier, A.V. Dorsselaer, C.A. Royer, M.A. Lazar, W. Bourguet, and H. Gronemeyer Chem. Biol. 16 2009 49 489
2. P. Germain, P. Chambon, G. Eichele, R. Evans, M.A. Lazar, M. Leid, A.R. deLera, R. Lotan, D.J. Mangelsdorf, and H. Gronemeyer Pharmacol. Rev. 58 2006 712 725
3. P. Germain, P. Chambon, G. Eichele, R.M. Evans, M.A. Lazar, M. Leid, A.R. de Lera, R. Lotan, D.J. Mangelsdorf, and H. Gronemeyer Pharmacol. Rev. 58 2006 760 772
4. V. Laudet, and H. Gronemeyer The Nuclear Receptor Facts Book 2002 Academic Press San Diego
5. M. Mark, N. Ghyselinck, and P. Chambon Annu. Rev. Pharmacol. Toxicol. 46 2006 451 480
6. L. Altucci, and H. Gronemeyer Nat. Rev. Cancer 1 2001 181 193
7. L. Altucci, M.D. Leibowitz, K.M. Ogilvie, A.R. de Lera, and H. Gronemeyer Nat. Rev. Drug Discov. 6 2007 793 810
8. A.I. Shulman, and D.J. Mangelsdorf N. Engl. J. Med. 353 2005 604 615
9. A. Chawla, Y.J. Repa, R.M. Evans, and D.J. Mangelsdorf Science 294 2001 1866 1870
10. J.J. Repa, and D.J. Mangelsdorf Nat. Med. 8 2002 1243 1248
11. B.C. Das, M.E. Smith, and G.V. Kalpana Bioorg. Med. Chem. Lett. 18 2008 4177
12. B.C. Das, M.E. Smith, and G.V. Kalpana Bioorg. Med. Chem. Lett. 18 2008 3805
13. Das, B. C.; Evans, T. Molecular Biosystem (communicated).
14. B.C. Das, and G.W. Kabalka Tetrahedron Lett. 49 2008 4695 4696
15. B.C. Das, S.M. Mahalingam, T. Evans, G.W. Kabalka, J. Anguiano, and K. Hema Chem. Comm. 2009 2133
16. B.C. Das, J. Anguiano, and S.M. Mahalingam Tetrahedron Lett. 50 2009 5670 5672
17. B.C. Das, K. McCartin, T.-C. Liu, R.T. Peterson, and T. Evans PloS ONE 2010 5
18. Smith, M. E.; Das, B. C.; Kalpana, G. V. Cancer Cell International, 2011, 11:34 doi: 10.1186/1475-2867-11-34
19. B.C. Das, X.-Y. Tang, S. Sanyal, S. Mohapatra, P. Rogler, S. Nayak, and T. Evans Tetrahedron Lett. 52 2011 2433 2435
20. M.P. Groziak G.C. Gribble, T.L. Gilchrist, Progress in Heterocyclic Chemistry Vol. 12 2000 Pergamon Oxford 1 21
21. C. Morin Tetrahedron 50 1994 12521 12569
22. W. Yang, X. Gao, and B. Wang Med. Res. Rev. 23 2003 346
23. D.S. Matterson Tetrahedron 45 1989 1859
24. Z.-Q. Tian, B.B. Brown, D.P. Mack, C.A. Hutton, and P.A. Bartlett J. Org. Chem. 62 1997 514
25. D. Leung, G. Abbenante, and D.P. Fairlie J. Med. Chem. 63 2003 1144
26. G.W. Kabalka, B.C. Das, and S. Das Tetrahedron Lett. 42 2001 7145 7146
27. Zhong, Y.; Wu, Y.; Liu, R.; Chuang, P.; Das, B.C.; Evans, T.; He, J.C. PloS ONE 2011, 6, e27945, doi:10.1371/journal.pone.0027945
28. L. Lee, M. Robb, M. Megan Lee, R. Davis, H. Mackay, S. Chavda, B. Babu, E.L. O'Brien, A.L. Risinger, L. Susan, S.L. Mooberry, and Moses Lee J. Med. Chem. 53 2010 325 334
29. B.C. Das, S.M. Mahalingam, and T. Evans Tetrahedron Lett. 50 2009 3031 3034
30. C. Zhang, G. Zhemg, L. Fang, and Y. Li Synlett 2006 475
31. Karl S.A. Vallin, Posaric David Wensbo, Zdenko Hamersak, Mats A. Svensson, and Alexander B.E. Minidis J. Org. Chem. 74 2009 9328
32. G.-B. Liang, and D.D. Feng Tetrahedron Lett. 37 1996 6627 6630